Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alliant Pharmaceuticals
Alpharetta, Georgia, USA
- Ownership
- Private
- Development stage
- Other
01
Overview
Alliant Pharmaceuticals was a specialty pharmaceutical company based in Alpharetta, Georgia, that focused on the pediatric and adult specialty markets. The company specialized in the development and commercialization of central nervous system (CNS) therapies, most notably for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Its lead product portfolio included Methylin (methylphenidate hydrochloride) in various oral formulations such as liquid and chewable tablets. In 2005, Alliant was acquired by Sciele Pharma for approximately $122 million. This acquisition significantly bolstered Sciele's presence in the pediatric and ADHD therapeutic sectors.
- Therapeutic areas
- Psychiatry
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Alliant Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alliant Pharmaceuticals.